Location History:
- Templeuve, FR (2006 - 2016)
- Tampleuve, FR (2017)
Company Filing History:
1 out of 73 
1 out of 1 
1 out of 4 
Years Active: 2006-2017
Title: **The Innovative Contributions of Daniel Poulain in Invasive Fungal Infection Diagnosis**
Introduction
Daniel Poulain, an accomplished inventor based in Templeuve, France, has made significant strides in the field of medical diagnostics. With a portfolio boasting four patents, his work primarily focuses on innovative methods for diagnosing invasive candidiasis and other invasive fungal infections.
Latest Patents
Poulain's recent patents showcase groundbreaking in vitro diagnostic methods. One notable invention addresses the diagnosis of invasive candidiasis in a subject by detecting the presence of aglycan and specific antibodies against proteins such as fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in blood, plasma, or serum samples. This invention additionally offers a method for determining appropriate treatment regimens for patients, accompanied by a kit for implementing these diagnostic approaches.
Another significant patent involves the use of MALDI-TOF mass spectrometry for diagnosing invasive fungal infections. This method entails analyzing a liquid biological sample from a mammal, which contains essential proteins and sugars. By extracting relevant compounds and determining their presence using MALDI-TOF mass spectrometry, Poulain's method effectively deduces whether the mammal has an invasive fungal infection, enhancing diagnostic accuracy in clinical settings.
Career Highlights
Daniel Poulain's professional journey includes contributions to notable organizations such as Lesaffre et Compagnie and Université du Droit et de la Santé Lille 2. His dedication to research and innovation within these institutions has been pivotal in advancing medical diagnostics.
Collaborations
Throughout his career, Poulain has collaborated with esteemed colleagues, including Boualem Sendid and Jean-Luc Simon. These partnerships have facilitated a rich exchange of ideas and propelled advancements in their research endeavors.
Conclusion
In summary, Daniel Poulain’s innovative contributions to the field of diagnostic methods for invasive fungal infections exemplify the impact a dedicated inventor can have on healthcare. As a professional based in France with multiple patents, Poulain continues to shape the future of medical diagnostics, facilitating improved patient outcomes in the fight against invasive infections.